Skip to main content

Barreto Rodney's Form 4 filing

Progressive Care Inc. (RXMD) · filed Jun 30, 2023

Accession no.
0001493152-23-023194
Filed
Jun 30, 2023, 5:33 PM ET
Trade date
Nov 16, 2022-May 9, 2023
Filing delay
226 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 8 derivative transactions. Open-market purchases total $1.00M. It was filed 226 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Barreto RodneyCIK 0001901402Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 9, 2023Common StockCConversionAcquired+228,240$2.20+$502,128318,517Indirect
May 9, 2023Common StockPPurchaseAcquired+455,000$2.20+$1,001,000773,517Indirect
May 9, 2023Common StockCConversionAcquired+570,599$2.20+$1,255,317.81,344,116Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 9, 2023Common StockCConversionDisposed−228,240$0.00–0Indirect
May 9, 2023Common StockPPurchaseAcquired+228,240$0.00F2$0228,240Indirect
May 9, 2023Common StockPPurchaseAcquired+30,000$0.00F3$030,000Direct
May 9, 2023Common StockPPurchaseAcquired+455,000$1,000,000.00+$455,000,000,000455,000IndirectPrice outlier
May 9, 2023Common StockCConversionDisposed−570,599$0.00–0Indirect
May 9, 2023Common StockPPurchaseAcquired+570,599$0.00F2$0798,839Indirect
Nov 16, 2022Convertible NoteCConversionDisposed––F5–0Indirect
Nov 16, 2022Convertible NoteCConversionAcquired––F5–0Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Pursuant to the Debt Conversion Agreement dated May 9, 2023, Issuer agreed to issue one warrant for a number of shares equal to the number of conversion shares issued to the Reporting Person. The warrants have a five-year term, are immediately exercisable, and have an exercise price of $2.20.

Referenced by the price of 2 transactions in Table II.

F3

On May 9, 2023, the Reporting Person was issued warrants to purchase 30,000 shares of common stock of the Issuer as an inducement to approve the transaction contemplated by the Securities Purchase Agreement dated May 5, 2023. The warrants have a three-year term, are immediately exercisable, and have an exercise price of $2.20.

Referenced by the price of 1 transaction in Table II.

F5

On May 9, 2023, NextPlat Corp entered into a First Amendment to the Securities Purchase Agreement dated November 16, 2022 (the "Debenture Purchase Agreement"), resulting in the cancellation of the "old" convertible note and the purchase of a replacement convertible note. Pursuant to the Amendment, NextPlat Corp agreed to amend the Debenture Purchase Agreement and the Form of Debenture to increase the conversion price to $2.20 per share. The debentures are convertible at any time, upon NextPlat Corp.'s election, to shares of the Issuer's common stock. No debentures have been purchased to date.

Referenced by the price of 2 transactions in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)